Business
Drugmaker Sues Rival Over Weight Loss Drug Advertising
Novo Nordisk sued Eli Lilly for false advertising regarding weight loss drug performance. The lawsuit alleges that Lilly used outdated studies to promote its products.
Coverage timeline — 1 article
The Hill
Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its weight loss drugs. The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound
2026-07-21 18:40 UTC